GSK (GSK) News Today GBX 1,488 +3.00 (+0.20%) As of 12:42 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesSustainabilityBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period GSK Studying If Blockbuster Shingles Shot Reduces Dementia RiskMarch 24 at 9:55 PM | bloomberg.comIs magic suddenly happening to the dirt cheap GSK share price?March 23 at 1:22 PM | msn.comWendy Becker Buys 536 Shares of GSK plc (LON:GSK) StockMarch 23 at 1:15 AM | americanbankingnews.comGSK plc (LON:GSK) Insider Purchases £8,120.40 in StockGSK plc (LON:GSK - Get Free Report) insider Wendy Becker acquired 536 shares of the company's stock in a transaction on Thursday, March 20th. The shares were bought at an average cost of GBX 1,515 ($19.64) per share, with a total value of £8,120.40 ($10,529.56).March 22 at 1:32 PM | marketbeat.comWendy Becker Acquires 536 Shares of GSK plc (LON:GSK) StockMarch 22 at 1:07 AM | insidertrades.comGSK (LON:GSK) Shares Cross Above 200 Day Moving Average - Here's WhyGSK (LON:GSK) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyMarch 21, 2025 | marketbeat.comGSK rallies Monday, outperforms marketMarch 17, 2025 | marketwatch.comGSK (LON:GSK) Shares Pass Above 200-Day Moving Average - Here's What HappenedGSK (LON:GSK) Stock Passes Above Two Hundred Day Moving Average - Here's WhyMarch 13, 2025 | marketbeat.comGSK plc (GSK) Stock ForecastsMarch 11, 2025 | finance.yahoo.comROSEN, A LONGSTANDING FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKMarch 10, 2025 | markets.businessinsider.comGSK shares rise for seven consecutive sessionsMarch 10, 2025 | msn.comGSK's (LON:GSK) Conservative Accounting Might Explain Soft EarningsMarch 6, 2025 | uk.finance.yahoo.comGSK plc (LON:GSK) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of GSK plc (LON:GSK - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and fivMarch 5, 2025 | marketbeat.comGSK says US FDA accepts two depemokimab indication submissionsMarch 3, 2025 | lse.co.ukGSK (LON:GSK) Shares Cross Above 200 Day Moving Average - Time to Sell?GSK (LON:GSK) Stock Crosses Above Two Hundred Day Moving Average - What's Next?March 2, 2025 | marketbeat.comGSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.February 28, 2025 | msn.comGSK proposes raising chief’s pay to as much as £21.6mn a yearFebruary 28, 2025 | ft.comGSK Drops Diversity Targets Amid BacklashFebruary 28, 2025 | marketwatch.comGSK rallies Tuesday, outperforms marketFebruary 25, 2025 | marketwatch.comGSK Eyes Growth in Cancer Drugs Amid Investor Pipeline ConcernFebruary 24, 2025 | bloomberg.comGSK completes acquisition of IDRxFebruary 24, 2025 | markets.businessinsider.comEmma Walmsley Sells 38,459 Shares of GSK plc (LON:GSK) StockGSK plc (LON:GSK - Get Free Report) insider Emma Walmsley sold 38,459 shares of the company's stock in a transaction dated Monday, February 17th. The shares were sold at an average price of GBX 1,418 ($17.97), for a total transaction of £545,348.62 ($691,014.47).February 22, 2025 | marketbeat.comGSK plc (LON:GSK) Insider Emma Walmsley Sells 38,459 SharesFebruary 22, 2025 | insidertrades.comGSK to sell 500K doses of bird flu vaccines to CanadaFebruary 20, 2025 | msn.comGSK Shares Gain Over 17% In 5 Days After Major Jump In Q3 ProfitsFebruary 18, 2025 | msn.comGSK reports FDA approves Penmenvy 5-in-1 meningococcal vaccineFebruary 17, 2025 | markets.businessinsider.comBillionaire’s hedge fund bets big against the GSK share price!February 17, 2025 | msn.comGSK’s Penmenvy meningococcal vaccine gains FDA approvalFebruary 17, 2025 | msn.comGoldman Sachs Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)February 17, 2025 | markets.businessinsider.comHere's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming DividendFebruary 15, 2025 | finance.yahoo.comGSK Q3FY25 Results: Net profit jumps 4X to ₹229 crore; revenue improves 18%February 14, 2025 | msn.comCitadel takes $384.5 million short position in GSK - FTFebruary 14, 2025 | msn.comGSK shares shorted by leading U.S. hedge fund, The Times reportsFebruary 14, 2025 | markets.businessinsider.comGSK plc (LON:GSK) Insider Sells £1,753,088.09 in StockGSK plc (LON:GSK - Get Free Report) insider Emma Walmsley sold 120,653 shares of the company's stock in a transaction on Monday, February 10th. The shares were sold at an average price of GBX 1,453 ($18.09), for a total transaction of £1,753,088.09 ($2,182,086.25).February 13, 2025 | marketbeat.comEmma Walmsley Sells 120,653 Shares of GSK plc (LON:GSK) StockGSK plc (LON:GSK - Get Free Report) insider Emma Walmsley sold 120,653 shares of GSK stock in a transaction on Monday, February 10th. The stock was sold at an average price of GBX 1,453 ($18.09), for a total value of £1,753,088.09 ($2,182,901.37).February 12, 2025 | marketbeat.comUlverston: GSK taskforce aims to allocate £2 million by JuneFebruary 12, 2025 | msn.comAnalysts Set GSK plc (LON:GSK) PT at GBX 1,805.83Shares of GSK plc (LON:GSK - Get Free Report) have been given an average rating of "Moderate Buy" by the seven research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and fivFebruary 11, 2025 | marketbeat.comGSK sued by Arizona AG for engaging in ‘deceptive’ practicesFebruary 8, 2025 | markets.businessinsider.comGSK plc (LON:GSK) Given Average Rating of "Moderate Buy" by AnalystsShares of GSK plc (LON:GSK - Get Free Report) have been given an average rating of "Moderate Buy" by the seven research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendFebruary 8, 2025 | marketbeat.comGSK launches $2.5 billion buyback, lifts sales target after stellar Q4February 7, 2025 | msn.comGSK Reported Strong Earnings, So I Reiterate My Strong BuyFebruary 7, 2025 | seekingalpha.comGSK is emerging from its long convalescenceFebruary 6, 2025 | ft.comGSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 BillionFebruary 5, 2025 | yahoo.comGSK (LON:GSK) Announces Quarterly Earnings ResultsGSK (LON:GSK - Get Free Report) posted its earnings results on Wednesday. The company reported GBX 23.20 ($0.29) EPS for the quarter. GSK had a return on equity of 33.30% and a net margin of 12.83%.February 5, 2025 | marketbeat.comGSK Sales, Core Earnings Expected to Fall -- Earnings PreviewFebruary 4, 2025 | marketwatch.comEuropean Commission authorizes Vocabria + Rekambys for HIV treatmentFebruary 1, 2025 | markets.businessinsider.comFTSE 100 forecast: BoE decision, Diageo, Vodafone, GSK earningsJanuary 31, 2025 | msn.comIs it game over for the GSK share price?January 31, 2025 | msn.comSheryl Lee Ralph Is Ready to Reunite With Denzel Washington for an ‘Adult Rom-Com’ (Exclusive)January 30, 2025 | msn.comGSK announces new drug applications accepted for review in China, JapanJanuary 28, 2025 | markets.businessinsider.com Remove Ads Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.970.63▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼75▲GSK Articles Average Week Remove Ads Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZN News Today ITH News Today HCM News Today GRI News Today INDV News Today BMY News Today OGN News Today GPH News Today IGC News Today ARTL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:GSK) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GSK Stock Free GSK Stock Alerts